Human TREX1-KO Dual Reporter THP-1 Cells

NF-κB-SEAP & IRF-Lucia reporter monocytes

ABOUT

TREX1 knockout NF-κB-SEAP and IRF-Lucia luciferase reporter monocytes

THP1-Dual™ KO-TREX1 cells were generated from THP1-Dual™ cells by stable biallelic knockout of the TREX1 gene. Human THP1 monocytes or derived macrophages are a common cellular model to study DNA sensing as they naturally express all cytosolic DNA sensors identified so far (except DAI). THP1-Dual™ KO-TREX1 cells feature two inducible reporter genes allowing the concomitant study of the IRF and NF-κB pathways, by monitoring the Lucia luciferase and SEAP (secreted embryonic alkaline phosphatase) activities, respectively.

TREX1 (three prime repair exonuclease 1) is a major cellular 3'->5' exonuclease that plays a crucial role in maintaining immune homeostasis [1,2].

 

Key features:

  • Biallelic knockout of the TREX1 gene
  • Functionally validated with a selection of PRR ligands and cytokines
  • Readily assessable Lucia luciferase and SEAP reporter activities

Applications:

  • Study of IRF and NF-κB-dependent TREX1 signaling pathways
  • Screening of interactions between TREX1 and other signaling protein
  • Study the role of TREX1 in innate immunity

 

1. Kavanagh D. et al., 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle. 7(12):1718-25.
2. Hasan M. & Yan N., 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol. 5:193.

Disclaimer:  These cells are for internal research use only and are covered by a Limited Use License (See Terms and Conditions). Additional rights may be available.

SPECIFICATIONS

Specifications

Target

TREX1

Target species

Human

Cell type
Monocytic
Growth properties
Suspension
Tissue origin
Human monocytes
Reporter gene
SEAP
Lucia®
Detection method
Colorimetric (SEAP), Bioluminescence (Lucia)
Antibiotic resistance
Blasticidin
Zeocin®
Growth medium

Complete RPMI 1640 (see TDS)

Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    THP1-Dual™ KO-TREX1 Cells
  • Cat code: 
    thpd-kotrex
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 tube of QUANTI-Luc™ 4 Reagent (sufficient to prepare 25 ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

TREX1 (also known as DNase III) is a major DNA-sensor nuclease in the cytoplasm.

The primary role of TREX1 is to target cellular DNA originating from aberrant replication and recombination [1]. TREX1 is bound to the ER (endoplasmic reticulum) and is able to degrade both single-stranded and double-stranded DNA as well as single-strand RNA. As a result, it blocks the activation of the cGAS-STING pathway, and thus dampening the nucleic acid sensor response. Therefore, it is thought to be a negative regulator of interferon (IFN) signaling preventing autoimmune diseases. Its acidic counterpart, DNase2, shares the same function, but is located in the lysosomes [2].

However,  TREX1 function also promotes protumor and -viral responses by degrading tumor- or virus-derived DNA that would otherwise stimulate the cGAS-STING pathway and elicit an immune response [2-3]. Unlike SAMHD1, another enzyme with nuclease activity, TREX1 boosts HIV-1 infection [4]. Mutations in TREX1 have been associated with a variety of disorders, such as the Aicardi–Goutières syndrome, Systemic Lupus Erythematosus or hereditary vascular retinopathy [1-4].

 

1. Kavanagh D. et al., 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle. 7(12):1718-25.
2. Baris, Adrian M et al., 2021. “Nucleic Acid Sensing in the Tumor Vasculature.” Cancers vol. 13,17 4452.
3. Hemphill et al., 2021. TREX1 as a Novel Immunotherapeutic Target. Front Immunol. Apr 1;12:660184.
4. Hasan M. & Yan N., 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol. 5:193 

DOCUMENTS

Documents

THP1-Dual™ KO-TREX1 Cells

Technical Data Sheet

Safety Data Sheet

Validation Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?